2009
Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis
Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA. Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis. Journal Of Women's Health 2009, 18: 311-319. PMID: 19281314, PMCID: PMC2858300, DOI: 10.1089/jwh.2008.0857.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsConfidence IntervalsControlled Clinical Trials as TopicFemaleFertilityFertility Agents, FemaleGonadotropin-Releasing HormoneHumansNeoplasmsOdds RatioOvaryPregnancyPregnancy OutcomePrimary Ovarian InsufficiencyPrognosisYoung AdultConceptsFollicle-stimulating hormoneOvarian functionOvarian preservationGnRH agonistGnRHa therapyRelative riskGnRHa-treated womenOvarian function preservationSummary relative riskRandom-effects modelEnglish-language literaturePremenopausal womenCombination chemotherapyRandomized trialsFunction preservationAutoimmune diseasesOvarian failureHematologic malignanciesMenstrual cycleReproductive agePreservation optionsGnRHaChemotherapyMeeting abstractsSmall study
2006
Management of adnexal mass.
Myers ER, Bastian LA, Havrilesky LJ, Kulasingam SL, Terplan MS, Cline KE, Gray RN, McCrory DC. Management of adnexal mass. Evidence Report Technology Assessment 2006, 1-145. PMID: 17854238, PMCID: PMC4781260.Peer-Reviewed Original ResearchConceptsCA 125Adnexal massesNatural historyOvarian cancerFollowup strategiesDiagnostic strategiesOverall complication rateNationwide Inpatient SamplePercent of womenAlternative diagnostic strategiesBimanual pelvic examinationMalignant adnexal massesRandom-effects modelImportant clinical informationPremenopausal womenComplication rateAsymptomatic massRadiologic findingsAdverse outcomesFDG-PETUnilocular cystInpatient SamplePelvic examinationStudy populationDiagnostic modalities